Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study
- PMID: 37001967
- PMCID: PMC10423464
- DOI: 10.1136/archdischild-2022-324269
Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study
Abstract
Objective: To assess the association between in utero exposure to seasonal inactivated influenza vaccine (IIV) and the risk of a diagnosis of a neurodevelopmental disorder in early childhood.
Design: Retrospective cohort study.
Setting: Population-based birth registry linked with health administrative databases in Western Australia (WA).
Participants: Singleton, liveborn children born between 1 April 2012 and 1 July 2016 in WA.
Exposure: Receipt of seasonal IIV during pregnancy obtained from a state-wide antenatal vaccination database.
Main outcome measures: Clinical diagnosis of a neurodevelopmental disorder was recorded from hospital inpatient and emergency department records. We used Cox proportional hazard regression, weighted by the inverse-probability of treatment (vaccination), to estimate the hazard ratio (HR) of neurodevelopmental disorders associated with in utero exposure to seasonal IIV.
Results: The study included 140 514 children of whom, 15 663 (11.2%) were exposed to seasonal IIV in utero. The prevalence of neurodevelopmental disorders was 5.4%, including mental or behavioural (0.4%), neurological (5.1%), seizure (2.2%) and sleep disorders (2.7%). Maternal IIV was not associated with increased risk of neurodevelopmental disorders (HR 1.00; 95% CI 0.91 to 1.08). Children exposed in the first trimester had a lower risk of seizure disorders (adjusted HR [aHR] 0.73; 95% CI 0.54 to 0.998), and preterm children exposed any time during pregnancy had a lower risk of sleep disorders (aHR 0.63; 95% CI 0.41 to 0.98).
Conclusions: We did not observe increased risk of neurodevelopmental disorders following in utero exposure to seasonal IIV. Although we observed some evidence for lower risk of seizure and sleep disorders, additional studies are required to confirm.
Keywords: epidemiology; infectious disease medicine; neurology.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.PLoS Med. 2022 Apr 5;19(4):e1003963. doi: 10.1371/journal.pmed.1003963. eCollection 2022 Apr. PLoS Med. 2022. PMID: 35381006 Free PMC article.
-
Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.Vaccine. 2022 Jun 15;40(27):3732-3736. doi: 10.1016/j.vaccine.2022.05.030. Epub 2022 May 20. Vaccine. 2022. PMID: 35606236
-
Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.JAMA. 2021 Jun 8;325(22):2285-2293. doi: 10.1001/jama.2021.6778. JAMA. 2021. PMID: 34100870 Free PMC article.
-
The risk of major structural birth defects associated with seasonal influenza vaccination during pregnancy: A population-based cohort study.Birth Defects Res. 2022 Nov 15;114(19):1244-1256. doi: 10.1002/bdr2.2049. Epub 2022 Jun 9. Birth Defects Res. 2022. PMID: 35678518 Free PMC article.
-
The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis.Am J Perinatol. 2016 Sep;33(11):1104-14. doi: 10.1055/s-0036-1586101. Epub 2016 Sep 7. Am J Perinatol. 2016. PMID: 27603545 Review.
References
-
- Vaccines against influenza WHO position paper – november 2012. Wkly Epidemiol Rec 2012;87:461–76. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous